David J. Grieve
97 Lisburn Road
Belfast, NIR, United Kingdom
Belfast, NIR, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 64 publications
Oncogenic snoRNA SNORD78 fuels colorectal cancer by protecting the m6A reader IMP2 to enhance phospholipid metabolism.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: July 14, 2026
Author Correction: Targeting QKI-7 in vivo restores endothelial cell function in diabetes.
Journal: Nature communications
Published: February 25, 2026
DNA/RNA Methylation-Driven Coronary Microvascular Dysfunction: Emerging Pathogenic Mechanisms and Therapeutic Opportunities for Heart Failure in Diabetes.
Journal: Cardiovascular drugs and therapy
Published: February 19, 2026
Systemic Loss of FKBPL Uncovers Diabetes-Dependent Pathways of Myocardial and Vascular Injury.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: February 12, 2026
Investigation of Biomarker Response to SGLT2 Inhibition in Heart Failure (SiN-HF).
Journal: Cardiovascular drugs and therapy
Published: October 15, 2025
Patient-specific iPSC-derived ECs identify QKI-7 as a key regulator of endothelial dysfunction and potential therapeutic target in diabetes.
Journal: Stem cells translational medicine
Published: October 09, 2025
Sacubitril/Valsartan as a Cardiac Radioprotector.
Journal: International journal of radiation oncology, biology, physics
Published: September 20, 2025
Epigenetic regulation by HDAC11-driven STAT3 activation promotes pro-inflammatory cytokine production and endothelial dysfunction upon bacterial infection in diabetes.
Journal: Cell communication and signaling : CCS
Published: July 22, 2025
Deep phenotyping of a modified diabetic cardiomyopathy mouse model which reflects clinical disease progression.
Journal: Diabetology & metabolic syndrome
Published: June 17, 2025
Proteome Alterations in Cardiac Fibroblasts: Insights from Experimental Myocardial Infarction and Clinical Ischaemic Cardiomyopathy.
Journal: International journal of molecular sciences
Published: March 04, 2025
Sacubitril/Valsartan attenuates progression of diabetic cardiomyopathy through immunomodulation properties: an opportunity to prevent progressive disease.
Journal: Cardiovascular diabetology
Published: December 18, 2024
Restoration of NOX4 signalling reverses endothelial colony-forming cell angiogenic dysfunction associated with experimental and clinical diabetes.
Journal: Stem cell research & therapy
Published: December 06, 2024
Last Updated: 09/26/2026